دورية أكاديمية
Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: a California Cancer Consortium Phase II study (NCI 7003).
| العنوان: | Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: a California Cancer Consortium Phase II study (NCI 7003). |
|---|---|
| المؤلفون: | Ramalingam, Suresh S, Davies, Angela M, Longmate, Jeffrey, Edelman, Martin J, Lara, Primo N, Vokes, Everett E, Villalona-Calero, Miguel, Gitlitz, Barbara, Reckamp, Karen, Salgia, Ravi, Wright, John J, Belani, Chandra P, Gandara, David R |
| المصدر: | J Thorac Oncol ; ISSN:1556-1380 ; Volume:6 ; Issue:10 |
| بيانات النشر: | Elsevier Science |
| سنة النشر: | 2011 |
| المجموعة: | PubMed Central (PMC) |
| الوصف: | Bronchioloalveolar carcinoma (BAC), a subtype of non-small cell lung cancer, is a difficult disease to treat with low response rates with cytotoxic chemotherapy. Bortezomib, a proteasome inhibitor, has demonstrated objective responses in patients with BAC in early-phase clinical trials. We conducted a phase II study of bortezomib in patients with advanced-stage BAC. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | https://doi.org/10.1097/JTO.0b013e318225924cTest; https://pubmed.ncbi.nlm.nih.gov/21716143Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220078Test/ |
| DOI: | 10.1097/JTO.0b013e318225924c |
| الإتاحة: | https://doi.org/10.1097/JTO.0b013e318225924cTest https://pubmed.ncbi.nlm.nih.gov/21716143Test https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220078Test/ |
| رقم الانضمام: | edsbas.5CEAD990 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1097/JTO.0b013e318225924c |
|---|